Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1985 Jul;49(1):36–39. doi: 10.1128/iai.49.1.36-39.1985

Effects of mycoplasma contamination on immunoglobulin biosynthesis by human B lymphoblastoid cell lines.

L Hendershot, D Levitt
PMCID: PMC262054  PMID: 3924831

Abstract

The synthesis and secretion of immunoglobulin M (IgM), as well as the relative ratio of membrane and secretory mu heavy chain (mu m and mu s, respectively), were evaluated in mycoplasma-contaminated B lymphoblastoid cell lines. The ratio of mu m to mu s was drastically lowered in infected cultures, and mu s chains could now combine with light chains. A 50 to 100% increase in IgM synthesis occurred in contaminated cultures, and small amounts of IgM were detectable in the culture media. These molecules possessed mu chains typical of secreted IgM. Reexpression of mu on the surface of B lymphoblastoid cells was substantially delayed in mycoplasma-contaminated cultures. Thus, mycoplasma contamination alters the synthesis and expression of a specific differentiated gene product (immunoglobulin) in B cell lines; such changes could significantly affect the interpretation of data on immunoglobulin synthesis by B cells with different phenotypes. This system may also provide a means of studying how mycoplasma infection alters specific gene expression in B cell lines.

Full text

PDF
36

Images in this article

37Image
on p.37
37Image
on p.37

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barile M. F. Mycoplasma infections of cell cultures. Isr J Med Sci. 1981 Jul;17(7):555–562. [PubMed] [Google Scholar]
  2. Beck J., Brunner H., Marcucci F., Kirchner H., Wietzerbin J. Induction of interferon by mycoplasmas in mouse spleen cell cultures. J Interferon Res. 1982;2(1):31–36. doi: 10.1089/jir.1982.2.31. [DOI] [PubMed] [Google Scholar]
  3. Chen T. R. In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain. Exp Cell Res. 1977 Feb;104(2):255–262. doi: 10.1016/0014-4827(77)90089-1. [DOI] [PubMed] [Google Scholar]
  4. Cole B. C., Washburn L. R., Sullivan G. J., Ward J. R. Specificity of a mycoplasma mitogen for lymphocytes from human and various animal hosts. Infect Immun. 1982 May;36(2):662–666. doi: 10.1128/iai.36.2.662-666.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fernald G. W. Immunological interactions between host cells and mycoplasmas: an introduction. Rev Infect Dis. 1982 May-Jun;4 (Suppl):S201–S204. doi: 10.1093/clinids/4.supplement_1.s201. [DOI] [PubMed] [Google Scholar]
  6. Hendershot L., Levitt D. Analysis of surface mu-chain expression in human lymphoblastoid cell lines that do not produce light chains. J Immunol. 1984 Jan;132(1):502–509. [PubMed] [Google Scholar]
  7. Hendershot L., Levitt D. Differential regulation of membrane and secretory mu chain synthesis in human beta cell lines. Regulation of membrane mu or secreted mu. J Exp Med. 1982 Dec 1;156(6):1622–1634. doi: 10.1084/jem.156.6.1622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Howell D. N., Machamer C. E., Cresswell P. Elimination of mycoplasma from human B-lymphoblastoid cell lines. Hum Immunol. 1982 Nov;5(3):233–238. doi: 10.1016/0198-8859(82)90136-7. [DOI] [PubMed] [Google Scholar]
  9. Klein E., Klein G., Nadkarni J. S., Nadkarni J. J., Wigzell H., Clifford P. Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines. Cancer Res. 1968 Jul;28(7):1300–1310. [PubMed] [Google Scholar]
  10. Kluve B., Merrick W. C., Gershman H. Mycoplasma-induced BALB/c 3T3 collagenase is a mammalian enzyme. Biochem J. 1983 Jun 15;212(3):641–647. doi: 10.1042/bj2120641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Melchers F., Andersson J. Synthesis, surface deposition and secretion of immunoglobulin M in bone marrow-derived lymphocytes before and after mitogenic stimulation. Transplant Rev. 1973;14:76–130. doi: 10.1111/j.1600-065x.1973.tb00103.x. [DOI] [PubMed] [Google Scholar]
  12. Naot Y. In vitro studies on the mitogenic activity of mycoplasmal species toward lymphocytes. Rev Infect Dis. 1982 May-Jun;4 (Suppl):S205–S209. doi: 10.1093/clinids/4.supplement_1.s205. [DOI] [PubMed] [Google Scholar]
  13. Schimke R. T., Berlin C. M., Sweeney E. W., Carroll W. R. The generation of energy by the arginine dihydrolase pathway in Mycoplasma hominis 07. J Biol Chem. 1966 May 25;241(10):2228–2236. [PubMed] [Google Scholar]
  14. Singer P. A., Singer H. H., Williamson A. R. Different species of messenger RNA encode receptor and secretory IgM mu chains differing at their carboxy termini. Nature. 1980 May 29;285(5763):294–300. doi: 10.1038/285294a0. [DOI] [PubMed] [Google Scholar]
  15. Stanbridge E. J. Mycoplasma detection-an obligation to scientific accuracy. Isr J Med Sci. 1981 Jul;17(7):563–568. [PubMed] [Google Scholar]
  16. Stanbridge E. Mycoplasmas and cell cultures. Bacteriol Rev. 1971 Jun;35(2):206–227. doi: 10.1128/br.35.2.206-227.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Williams P. B., Kubo R. T., Grey H. M. mu-Chains from a nonsecretor B cell line differ from secreted mu-chains at the C-terminal end. J Immunol. 1978 Dec;121(6):2435–2439. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES